Additionally, immunofluorescent staining of GSDMD, caspase‐1, and IL‐1β with Iba‐1 generated another line of evidence for enhanced microglial pyroptosis following stroke, whereas A151 treatment significantly suppressed such an increase (Fig 3D and E). Here, IL1B is linked to stroke disorder.